The French startup Bioptimus is developing an artificial intelligence model to understand the different scales of life, from molecules to patients. Its first model, H-optimus-0, released as open-source, analyzes cancer tissue images to improve diagnostics and predict treatments. Bioptimus aims to create a knowledge engine capable of capturing the essence of biology and improving global health by collaborating with players in the pharmaceutical and biotech industries.
Bioptimus aims to revolutionize biology with AI
Help us improve this article
- Add a clear point? Share it in comment.
- Spot an error? Provide the correction and source.
- Broken link? Share a working alternative.
Your feedback helps keep the content accurate and valuable.
